Peer-reviewedLicence not statedFuture Oncology20 Oct 2026

Real-world effectiveness of first-line chemoimmunotherapy versus chemotherapy in older adults with extensive-stage small cell lung cancer: an inverse probability treatment weighted analysis

Siyuan Cui^1,2,3
Kui Zhao^1,2,3
Na Wang^1,2,3
Yuan Meng^1,2,3
Xiaoshan Wang^1,2,3
Chaoran Wang^1,2,3
Fanming Kong^1,2,3

¹Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
²National Clinical Research Center for Chinese Medicine, Tianjin, China
³Tianjin Cancer Institute of Traditional Chinese Medicine, Tianjin, China

Cost-effectiveness of disitamab vedotin plus toripalimab versus chemotherapy alone as first-line treatment for HER2-overexpressing advanced urothelial carcinoma: a cost-effectiveness analysis from the Chinese healthcare system perspective
Yang Liu, Lin Qiao, Xiaofei Li +6
Frontiers in Oncology4 Nov 2026Peer-reviewedCC BY 4.0OncologyFrontiersCrossref
Disrupting the NAD+/NAM metabolic ratio driven by IL-1β inflammatory response potentiates chemotherapy and chemoimmunotherapy in mice
Fuxue Xing, Hongwei Lv, Liang Wang +16
Nature Communications13 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
Cost-effectiveness of datopotamab deruxtecan versus chemotherapy as a first-line treatment for patients with advanced triple-negative breast cancer
Zuojuan Xiang, Qiao Xia, Zhengxiong Li
Frontiers in Pharmacology6 Nov 2026Peer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
A Retrospective Study of the Efficacy and Safety of Chemoimmunotherapy in Elderly Patients with Extensive-Stage Small Cell Lung Cancer.
Minoru Kobayashi, Satoshi Watanabe, Shinji Hirose +23
Cancers27 Sep 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Efficacy comparison of neoadjuvant chemotherapy, chemoradiotherapy, and chemoimmunotherapy in resectable esophageal squamous cell carcinoma: short- and long-term outcomes from a propensity score-matched analysis
Hai Zhang, Yujing Liang, Chaolin Li +3
Frontiers in medicine19 Oct 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC

Cite

BibTeX

@article{cui2026realworld,
  title = {{Real-world effectiveness of first-line chemoimmunotherapy versus chemotherapy in older adults with extensive-stage small cell lung cancer: an inverse probability treatment weighted analysis}},
  author = {Siyuan Cui and Kui Zhao and Na Wang and Yuan Meng and Xiaoshan Wang and Chaoran Wang and Fanming Kong},
  journal = {Future Oncology},
  year = {2026},
  month = oct,
  doi = {10.1080/14796694.2026.2750718},
  url = {https://doi.org/10.1080/14796694.2026.2750718},
}

RIS

TY  - JOUR
TI  - Real-world effectiveness of first-line chemoimmunotherapy versus chemotherapy in older adults with extensive-stage small cell lung cancer: an inverse probability treatment weighted analysis
AU  - Siyuan Cui
AU  - Kui Zhao
AU  - Na Wang
AU  - Yuan Meng
AU  - Xiaoshan Wang
AU  - Chaoran Wang
AU  - Fanming Kong
PY  - 2026
DA  - 2026/10/20
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2750718
UR  - https://doi.org/10.1080/14796694.2026.2750718
SN  - 1479-6694
SN  - 1744-8301
ER  -

Related

Cite